| Factor V Leiden mutation and deep venous thrombosis in a patient with hypereosinophilic syndrome. | |
| | |
MedLine Citation:
|
PMID: 16951787 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Idiopathic hypereosinophilic syndrome is a rare condition characterized by extremely high peripheral blood eosinophil counts. Patients with idiopathic hypereosinophilic syndrome are at increased risk for thrombosis. The coexistence of idiopathic hypereosinophilic syndrome with other thrombotic disease is rare. We present an additional case of idiopathic hypereosinophilic syndrome and factor V Leiden mutation, which lead to deep vein thrombosis. |
| | |
Authors:
|
Vahap Aslan; Emre Entok |
Related Documents
:
|
6231147 - The syndrome of iga nephropathy. 5412947 - Hypocalcaemic primary hyperparathyroidism. 2603267 - Solitary cutaneous leiomyomata: a clinicopathological study of 28 cases. 19662467 - Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura i... 3584577 - Pibi(d)s syndrome--trichothiodystrophy with xeroderma pigmentosum (group d) mutation. 19729547 - Tracheal chondrosarcoma--a rare complication in maffucci syndrome. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Saudi medical journal Volume: 27 ISSN: 0379-5284 ISO Abbreviation: Saudi Med J Publication Date: 2006 Sep |
Date Detail:
|
Created Date: 2006-09-04 Completed Date: 2007-05-18 Revised Date: 2008-06-23 |
Medline Journal Info:
|
Nlm Unique ID: 7909441 Medline TA: Saudi Med J Country: Saudi Arabia |
Other Details:
|
Languages: eng Pagination: 1418-20 Citation Subset: IM |
Affiliation:
|
Department of Hematology, Yunus Emre State Hospital, Osmangazi University, Turkey. aslanvahap@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anticoagulants / therapeutic use* Coumarins / therapeutic use* Enzyme Inhibitors / therapeutic use* Factor V / genetics* Heparin, Low-Molecular-Weight / therapeutic use* Humans Hydroxyurea / therapeutic use* Hypereosinophilic Syndrome / blood* Leg Male Mutation Venous Thrombosis / drug therapy*, genetics*, radionuclide imaging |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Coumarins; 0/Enzyme Inhibitors; 0/Heparin, Low-Molecular-Weight; 0/factor V Leiden; 127-07-1/Hydroxyurea; 9001-24-5/Factor V; 91-64-5/coumarin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Crossing renal vessel causing ureteropelvic junction obstruction.
Next Document: Evaluation of the dead space to tidal volume ratio as a predictor of extubation failure.